Eikon Therapeutics

Last updated: May 06, 2024

Roger Perlmutter, CEO
Roger Perlmutter, CEO
Country: USA | Funding: $772M (+)

Website: https://www.eikontx.com/

Eikon is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.